Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 12 March, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo

Lupin Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 8, 2025, 1:29 pm

Market Cap 92,678 Cr.
Current Price 2,030
High / Low 2,403/1,493
Stock P/E32.3
Book Value 343
Dividend Yield0.39 %
ROCE15.7 %
ROE14.1 %
Face Value 2.00
PEG Ratio1.74

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Lupin Ltd

Competitors of Lupin Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
MPS Pharmaa Ltd 6.71 Cr. 3.51 4.33/3.05 0.800.00 %9.15 %34.9 % 10.0
Gujarat Themis Biosyn Ltd 2,663 Cr. 244 390/19250.6 20.50.27 %45.0 %33.8 % 1.00
Gujarat Terce Laboratories Ltd 53.1 Cr. 71.5 94.9/32.118.0 11.90.00 %9.72 %3.44 % 10.0
Gujarat Inject (Kerala) Ltd 38.0 Cr. 26.0 29.0/8.7438.8 6.640.00 %2.65 %2.08 % 10.0
Godavari Drugs Ltd 70.4 Cr. 93.5 155/79.011.4 55.40.00 %14.4 %15.5 % 10.0
Industry Average17,255.37 Cr1,081.8442.42185.800.37%16.00%16.32%6.27

All Competitor Stocks of Lupin Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 4,1613,8833,7444,1464,3224,4304,8145,0395,1974,9615,6005,6735,768
Expenses 3,7913,6153,5123,6933,7903,8523,9584,1214,1593,9644,3594,3324,412
Operating Profit 3702682324535335788569181,0389971,2411,3401,356
OPM % 9%7%6%11%12%13%18%18%20%20%22%24%24%
Other Income 3416615183723402929684254
Interest 33414355849386817471687167
Depreciation 203327193203220264235248257457248257271
Profit before tax 167-8522102462585596307364989931,0551,071
Tax % -229%502%3,925%36%36%6%19%21%16%26%19%19%20%
Net Profit 549-512-87134158242453495619368806859859
EPS in Rs 12.01-11.40-1.962.853.375.199.9410.7613.477.8917.5818.6918.74

Last Updated: February 28, 2025, 6:41 pm

Below is a detailed analysis of the quarterly data for Lupin Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is ₹5,768.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,673.00 Cr. (Sep 2024) to ₹5,768.00 Cr., marking an increase of ₹95.00 Cr..
  • For Expenses, as of Dec 2024, the value is ₹4,412.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,332.00 Cr. (Sep 2024) to ₹4,412.00 Cr., marking an increase of ₹80.00 Cr..
  • For Operating Profit, as of Dec 2024, the value is ₹1,356.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,340.00 Cr. (Sep 2024) to ₹1,356.00 Cr., marking an increase of ₹16.00 Cr..
  • For OPM %, as of Dec 2024, the value is 24.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 24.00%.
  • For Other Income, as of Dec 2024, the value is ₹54.00 Cr.. The value appears strong and on an upward trend. It has increased from 42.00 Cr. (Sep 2024) to ₹54.00 Cr., marking an increase of ₹12.00 Cr..
  • For Interest, as of Dec 2024, the value is ₹67.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 71.00 Cr. (Sep 2024) to ₹67.00 Cr., marking a decrease of 4.00 Cr..
  • For Depreciation, as of Dec 2024, the value is ₹271.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 257.00 Cr. (Sep 2024) to ₹271.00 Cr., marking an increase of ₹14.00 Cr..
  • For Profit before tax, as of Dec 2024, the value is ₹1,071.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,055.00 Cr. (Sep 2024) to ₹1,071.00 Cr., marking an increase of ₹16.00 Cr..
  • For Tax %, as of Dec 2024, the value is 20.00%. The value appears to be increasing, which may not be favorable. It has increased from 19.00% (Sep 2024) to 20.00%, marking an increase of 1.00%.
  • For Net Profit, as of Dec 2024, the value is ₹859.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 859.00 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 18.74. The value appears strong and on an upward trend. It has increased from ₹18.69 (Sep 2024) to 18.74, marking an increase of ₹0.05.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 3:38 pm

MetricMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 9,64111,28612,77014,25617,36715,79714,66515,37515,16316,40516,64220,01122,002
Expenses 7,3568,2719,14610,56412,86512,64912,10413,02012,59616,18714,92116,21117,067
Operating Profit 2,2843,0153,6243,6914,5023,1482,5612,3552,5672191,7213,8004,934
OPM % 24%27%28%26%26%20%17%15%17%1%10%19%22%
Other Income 13105235184106-1,31091-134138210151131193
Interest 41271059153204302363141143274312277
Depreciation 3322614354879121,0868469708871,6598811,1971,233
Profit before tax 1,9252,8323,4153,3293,5435471,5038871,676-1,3727162,4223,617
Tax % 30%34%28%32%28%53%59%130%27%10%38%20%
Net Profit 1,3401,8702,4442,2702,565258615-2701,228-1,5284481,9362,892
EPS in Rs 29.3640.9653.4750.1756.635.5613.40-5.9526.81-33.629.4542.0162.90
Dividend Payout % 14%15%14%15%13%90%37%-101%24%-12%42%19%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)39.55%30.70%-7.12%13.00%-89.94%138.37%-143.90%554.81%-224.43%129.32%332.14%
Change in YoY Net Profit Growth (%)0.00%-8.86%-37.81%20.12%-102.94%228.31%-282.27%698.72%-779.24%353.75%202.82%

Lupin Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:6%
5 Years:6%
3 Years:10%
TTM:13%
Compounded Profit Growth
10 Years:0%
5 Years:21%
3 Years:17%
TTM:60%
Stock Price CAGR
10 Years:1%
5 Years:27%
3 Years:38%
1 Year:20%
Return on Equity
10 Years:8%
5 Years:2%
3 Years:2%
Last Year:14%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 8:37 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 90909090909090919191919191
Reserves 5,1156,8428,78411,07313,40713,48713,65212,44613,71212,06212,37414,19915,551
Borrowings 1,1646545377,1787,9667,1438,4966,3055,1294,1584,5422,9223,442
Other Liabilities 2,4752,5503,6423,9574,7495,3005,4235,9684,4985,3405,7946,5396,398
Total Liabilities 8,84310,13513,05422,29826,21226,02027,66124,81023,43021,65122,80023,75125,482
Fixed Assets 3,0003,3564,3688,71711,03310,36211,0877,9387,8817,3828,3558,8789,062
CWIP 3113045762,7022,1332,5981,6409401,0661,1461,238773635
Investments 21781,658162,1362622,2952,3742,4559005171,0751,575
Other Assets 5,5306,2976,45110,86210,91012,79812,63913,55712,02812,22412,69013,02614,209
Total Assets 8,84310,13513,05422,29826,21226,02027,66124,81023,43021,65122,80023,75125,482

Below is a detailed analysis of the balance sheet data for Lupin Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹91.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹91.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹15,551.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹14,199.00 Cr. (Mar 2024) to ₹15,551.00 Cr., marking an increase of 1,352.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹3,442.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹2,922.00 Cr. (Mar 2024) to ₹3,442.00 Cr., marking an increase of 520.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹6,398.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹6,539.00 Cr. (Mar 2024) to ₹6,398.00 Cr., marking a decrease of 141.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹25,482.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹23,751.00 Cr. (Mar 2024) to ₹25,482.00 Cr., marking an increase of 1,731.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹9,062.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹8,878.00 Cr. (Mar 2024) to ₹9,062.00 Cr., marking an increase of 184.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹635.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹773.00 Cr. (Mar 2024) to ₹635.00 Cr., marking a decrease of 138.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹1,575.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,075.00 Cr. (Mar 2024) to ₹1,575.00 Cr., marking an increase of 500.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹14,209.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹13,026.00 Cr. (Mar 2024) to ₹14,209.00 Cr., marking an increase of 1,183.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹25,482.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹23,751.00 Cr. (Mar 2024) to ₹25,482.00 Cr., marking an increase of 1,731.00 Cr..

Notably, the Reserves (₹15,551.00 Cr.) exceed the Borrowings (3,442.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +1,2512,0042,733-3824,1141,7511,6661,4691,8223671,8973,648
Cash from Investing Activity +-522-851-1,034-6,769-2,527470-3,2821,107-1,2401,292-1,287-1,712
Cash from Financing Activity +-663-857-1975,836433-1,492744-891-1,885-1,572-337-2,184
Net Cash Flow662961,502-1,3152,019729-8721,685-1,30387273-248

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow1.00-651.00-534.00-4.00-3.00-4.00-6.00-4.00-3.00215.00-3.001.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days83807611691120128129108959886
Inventory Days200204220276266253283232279261242272
Days Payable159152172168189178184162137129136163
Cash Conversion Cycle125131124225167195227199249227204195
Working Capital Days92946714711213715492151135127103
ROCE %33%41%40%24%19%10%10%9%9%-7%6%16%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters46.78%47.10%47.11%47.10%47.08%47.07%47.06%47.04%47.01%46.99%46.96%46.94%
FIIs14.65%14.27%13.81%13.98%13.32%13.93%14.99%16.11%18.29%19.32%21.50%22.04%
DIIs26.91%26.89%27.63%29.39%28.92%29.08%29.14%29.72%27.76%26.77%25.10%24.73%
Government0.29%0.29%0.00%0.00%0.28%0.28%0.28%0.01%0.01%0.01%0.01%0.01%
Public11.37%11.45%11.45%9.51%10.39%9.62%8.52%7.10%6.93%6.92%6.44%6.27%
No. of Shareholders3,78,5473,82,8283,78,0113,60,6773,48,1493,22,6782,89,0742,81,5422,80,2482,88,5372,79,2802,81,988

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HDFC Balanced Advantage Fund - Regular Plan5,852,1651.03660.212,687,8872025-03-10117.72%
ICICI Prudential Bluechip Fund5,051,5561.38569.892,687,8872025-03-1087.94%
ICICI Prudential Value Discovery Fund4,451,8181.55502.232,687,8872025-03-1065.63%
HDFC Flexi Cap Fund - Regular Plan4,250,0001.22479.462,687,8872025-03-1058.12%
Mirae Asset Emerging Bluechip Fund4,055,5851.63457.532,687,8872025-03-1050.88%
HDFC Top 100 Fund - Regular Plan3,369,0131.47380.082,687,8872025-03-1025.34%
Mirae Asset Midcap Fund2,934,0862.81331.012,687,8872025-03-109.16%
SBI Long Term Equity Fund2,687,8871.92303.232,687,8872025-03-100%
ICICI Prudential Multi Asset Fund2,004,2920.91226.112,687,8872025-03-10-25.43%
ICICI Prudential Large & Mid Cap Fund1,584,8502.02178.792,687,8872025-03-10-41.04%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 42.059.46-33.6526.84-5.95
Diluted EPS (Rs.) 41.879.41-33.6526.72-5.95
Cash EPS (Rs.) 68.7429.203.2846.5915.38
Book Value[Excl.RevalReserv]/Share (Rs.) 315.41275.67268.91305.45277.73
Book Value[Incl.RevalReserv]/Share (Rs.) 315.41275.67268.91305.45277.73
Revenue From Operations / Share (Rs.) 439.12365.75360.96334.21339.40
PBDIT / Share (Rs.) 86.2641.139.4459.5862.66
PBIT / Share (Rs.) 59.9921.78-27.0640.0241.24
PBT / Share (Rs.) 53.1515.75-30.2036.9216.63
Net Profit / Share (Rs.) 42.479.84-33.2227.04-6.04
NP After MI And SOA / Share (Rs.) 42.019.45-33.6226.81-5.95
PBDIT Margin (%) 19.6411.242.6117.8218.46
PBIT Margin (%) 13.665.95-7.4911.9712.15
PBT Margin (%) 12.104.30-8.3611.044.89
Net Profit Margin (%) 9.672.69-9.208.08-1.78
NP After MI And SOA Margin (%) 9.562.58-9.318.02-1.75
Return on Networth / Equity (%) 13.393.45-12.578.81-2.14
Return on Capital Employeed (%) 17.647.23-9.0711.9611.85
Return On Assets (%) 7.971.87-7.005.15-1.07
Long Term Debt / Equity (X) 0.000.000.010.000.14
Total Debt / Equity (X) 0.180.340.310.220.34
Asset Turnover Ratio (%) 0.850.500.510.470.45
Current Ratio (X) 1.581.341.511.661.67
Quick Ratio (X) 0.990.850.941.171.30
Inventory Turnover Ratio (X) 0.870.820.770.880.87
Dividend Payout Ratio (NP) (%) 9.5042.28-19.3122.34-84.00
Dividend Payout Ratio (CP) (%) 5.8513.87225.8212.9232.29
Earning Retention Ratio (%) 90.5057.72119.3177.66184.00
Cash Earning Retention Ratio (%) 94.1586.13-125.8287.0867.71
Interest Coverage Ratio (X) 12.616.823.0019.227.82
Interest Coverage Ratio (Post Tax) (X) 7.212.63-9.579.721.96
Enterprise Value (Cr.) 75275.9532506.4236722.7147698.5728589.60
EV / Net Operating Revenue (X) 3.761.952.243.151.86
EV / EBITDA (X) 19.1517.3785.6217.6510.07
MarketCap / Net Operating Revenue (X) 3.681.772.073.051.74
Retention Ratios (%) 90.4957.71119.3177.65184.00
Price / BV (X) 5.162.362.793.362.13
Price / Net Operating Revenue (X) 3.681.772.073.051.74
EarningsYield 0.020.01-0.040.02-0.01

After reviewing the key financial ratios for Lupin Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 42.05. This value is within the healthy range. It has increased from 9.46 (Mar 23) to 42.05, marking an increase of 32.59.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 41.87. This value is within the healthy range. It has increased from 9.41 (Mar 23) to 41.87, marking an increase of 32.46.
  • For Cash EPS (Rs.), as of Mar 24, the value is 68.74. This value is within the healthy range. It has increased from 29.20 (Mar 23) to 68.74, marking an increase of 39.54.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 315.41. It has increased from 275.67 (Mar 23) to 315.41, marking an increase of 39.74.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 315.41. It has increased from 275.67 (Mar 23) to 315.41, marking an increase of 39.74.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 439.12. It has increased from 365.75 (Mar 23) to 439.12, marking an increase of 73.37.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 86.26. This value is within the healthy range. It has increased from 41.13 (Mar 23) to 86.26, marking an increase of 45.13.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 59.99. This value is within the healthy range. It has increased from 21.78 (Mar 23) to 59.99, marking an increase of 38.21.
  • For PBT / Share (Rs.), as of Mar 24, the value is 53.15. This value is within the healthy range. It has increased from 15.75 (Mar 23) to 53.15, marking an increase of 37.40.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 42.47. This value is within the healthy range. It has increased from 9.84 (Mar 23) to 42.47, marking an increase of 32.63.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 42.01. This value is within the healthy range. It has increased from 9.45 (Mar 23) to 42.01, marking an increase of 32.56.
  • For PBDIT Margin (%), as of Mar 24, the value is 19.64. This value is within the healthy range. It has increased from 11.24 (Mar 23) to 19.64, marking an increase of 8.40.
  • For PBIT Margin (%), as of Mar 24, the value is 13.66. This value is within the healthy range. It has increased from 5.95 (Mar 23) to 13.66, marking an increase of 7.71.
  • For PBT Margin (%), as of Mar 24, the value is 12.10. This value is within the healthy range. It has increased from 4.30 (Mar 23) to 12.10, marking an increase of 7.80.
  • For Net Profit Margin (%), as of Mar 24, the value is 9.67. This value is within the healthy range. It has increased from 2.69 (Mar 23) to 9.67, marking an increase of 6.98.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.56. This value is within the healthy range. It has increased from 2.58 (Mar 23) to 9.56, marking an increase of 6.98.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 13.39. This value is below the healthy minimum of 15. It has increased from 3.45 (Mar 23) to 13.39, marking an increase of 9.94.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 17.64. This value is within the healthy range. It has increased from 7.23 (Mar 23) to 17.64, marking an increase of 10.41.
  • For Return On Assets (%), as of Mar 24, the value is 7.97. This value is within the healthy range. It has increased from 1.87 (Mar 23) to 7.97, marking an increase of 6.10.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.18. This value is within the healthy range. It has decreased from 0.34 (Mar 23) to 0.18, marking a decrease of 0.16.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.85. It has increased from 0.50 (Mar 23) to 0.85, marking an increase of 0.35.
  • For Current Ratio (X), as of Mar 24, the value is 1.58. This value is within the healthy range. It has increased from 1.34 (Mar 23) to 1.58, marking an increase of 0.24.
  • For Quick Ratio (X), as of Mar 24, the value is 0.99. This value is below the healthy minimum of 1. It has increased from 0.85 (Mar 23) to 0.99, marking an increase of 0.14.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.87. This value is below the healthy minimum of 4. It has increased from 0.82 (Mar 23) to 0.87, marking an increase of 0.05.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 9.50. This value is below the healthy minimum of 20. It has decreased from 42.28 (Mar 23) to 9.50, marking a decrease of 32.78.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 5.85. This value is below the healthy minimum of 20. It has decreased from 13.87 (Mar 23) to 5.85, marking a decrease of 8.02.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 90.50. This value exceeds the healthy maximum of 70. It has increased from 57.72 (Mar 23) to 90.50, marking an increase of 32.78.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 94.15. This value exceeds the healthy maximum of 70. It has increased from 86.13 (Mar 23) to 94.15, marking an increase of 8.02.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 12.61. This value is within the healthy range. It has increased from 6.82 (Mar 23) to 12.61, marking an increase of 5.79.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 7.21. This value is within the healthy range. It has increased from 2.63 (Mar 23) to 7.21, marking an increase of 4.58.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 75,275.95. It has increased from 32,506.42 (Mar 23) to 75,275.95, marking an increase of 42,769.53.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 3.76. This value exceeds the healthy maximum of 3. It has increased from 1.95 (Mar 23) to 3.76, marking an increase of 1.81.
  • For EV / EBITDA (X), as of Mar 24, the value is 19.15. This value exceeds the healthy maximum of 15. It has increased from 17.37 (Mar 23) to 19.15, marking an increase of 1.78.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 3.68. This value exceeds the healthy maximum of 3. It has increased from 1.77 (Mar 23) to 3.68, marking an increase of 1.91.
  • For Retention Ratios (%), as of Mar 24, the value is 90.49. This value exceeds the healthy maximum of 70. It has increased from 57.71 (Mar 23) to 90.49, marking an increase of 32.78.
  • For Price / BV (X), as of Mar 24, the value is 5.16. This value exceeds the healthy maximum of 3. It has increased from 2.36 (Mar 23) to 5.16, marking an increase of 2.80.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 3.68. This value exceeds the healthy maximum of 3. It has increased from 1.77 (Mar 23) to 3.68, marking an increase of 1.91.
  • For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 23) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Lupin Ltd as of March 12, 2025 is: ₹1,254.57

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Lupin Ltd is Overvalued by 38.20% compared to the current share price 2,030.00

Intrinsic Value of Lupin Ltd as of March 12, 2025 is: 1,487.87

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Lupin Ltd is Overvalued by 26.71% compared to the current share price 2,030.00

Last 5 Year EPS CAGR: 18.60%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 17.50%, which is a positive sign.
  2. The company has higher reserves (11,746.46 cr) compared to borrowings (4,587.38 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (15.08 cr) and profit (166.77 cr) over the years.
  1. The stock has a high average Working Capital Days of 117.58, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 189.00, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Lupin Ltd:
    1. Net Profit Margin: 9.67%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 17.64% (Industry Average ROCE: 16%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 13.39% (Industry Average ROE: 16.32%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 7.21
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.99
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 32.3 (Industry average Stock P/E: 42.42)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.18
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Lupin Ltd. is a Public Limited Listed company incorporated on 01/03/1983 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24100MH1983PLC029442 and registration number is 029442. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 14666.50 Cr. and Equity Capital is Rs. 91.14 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
PharmaceuticalsKalpataru Inspire, 3rd Floor, Mumbai Maharashtra 400055info@lupin.com
http://www.lupin.com
Management
NamePosition Held
Mrs. Manju D GuptaChairman
Mr. Nilesh D GuptaManaging Director
Ms. Vinita GuptaDirector & CEO
Mr. Ramesh SwaminathanExecutive Director & Global CFO
Mr. Mark D McDadeIndependent Director
Dr. Punita Kumar-SinhaIndependent Director
Mr. Jean-Luc BelingardIndependent Director
Mr. Jeffrey KindlerIndependent Director
Mr. Alfonso ZuluetaIndependent Director

FAQ

What is the latest intrinsic value of Lupin Ltd?

The latest intrinsic value of Lupin Ltd as on 09 March 2025 is ₹1254.57, which is 38.20% lower than the current market price of 2,030.00, indicating the stock is overvalued by 38.20%. The intrinsic value of Lupin Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹92,678 Cr. and recorded a high/low of ₹2,403/1,493 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹15,551 Cr and total liabilities of ₹25,482 Cr.

What is the Market Cap of Lupin Ltd?

The Market Cap of Lupin Ltd is 92,678 Cr..

What is the current Stock Price of Lupin Ltd as on 09 March 2025?

The current stock price of Lupin Ltd as on 09 March 2025 is ₹2,030.

What is the High / Low of Lupin Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Lupin Ltd stocks is ₹2,403/1,493.

What is the Stock P/E of Lupin Ltd?

The Stock P/E of Lupin Ltd is 32.3.

What is the Book Value of Lupin Ltd?

The Book Value of Lupin Ltd is 343.

What is the Dividend Yield of Lupin Ltd?

The Dividend Yield of Lupin Ltd is 0.39 %.

What is the ROCE of Lupin Ltd?

The ROCE of Lupin Ltd is 15.7 %.

What is the ROE of Lupin Ltd?

The ROE of Lupin Ltd is 14.1 %.

What is the Face Value of Lupin Ltd?

The Face Value of Lupin Ltd is 2.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Lupin Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE